http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-610346-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e1503069238009851ded999ea9ad833 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 |
filingDate | 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451e9110318575b2fcb4865edfb5fc27 |
publicationDate | 2015-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | NZ-610346-A |
titleOfInvention | Hyaluronic acid based formulations |
abstract | Discloses a method of making a soft tissue filler composition comprising the steps of: preparing a crosslinked hyaluronic acid (HA) gel comprising a mixture of a first, low molecular weight HA material and a second, high molecular weight HA material, the second, high molecular weight HA material having a weight average molecular weight of at least twice that of the first, low molecular weight material, the mixture comprising more than about 50% by weight of the first, low molecular weight HA material, wherein the HA materials are hyaluronic acid or one or more salts thereof; adjusting the HA concentration in the crosslinked HA gel to between about 15.0 mg/g and about 20.0 mg/g; preparing a solution comprising an uncrosslinked HA and/or a salt thereof having a weight average molecular weight of between at least about 1.0 MDa and about 4.0 MDa, the solution having a total HA and HA salt concentration of between about 10 mg/g and about 50 mg/g; and combining the gel with the solution. |
priorityDate | 2010-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.